Article Details

Immutep in second collaborative oncology trial with Merck and Pfizer - BioPharma-Reporter

Retrieved on: 2022-12-05 23:32:13

Tags for this article:

Click the tags to see associated articles and topics

Immutep in second collaborative oncology trial with Merck and Pfizer - BioPharma-Reporter. View article details on HISWAI: https://www.biopharma-reporter.com/Article/2022/12/05/Immutep-in-second-collaborative-oncology-trial-with-Merck-and-Pfizer

Excerpt

Australia-based, Immutep, this week announced a further extension to its immuno-oncology clinical pipeline.

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up